MetaCap

Alkermes (ALKS) News

NASDAQ: ALKSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

44.94-1.24 (-2.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ALKS news summary

We found 8 recent headlines mentioning Alkermes (ALKS): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, Business Wire. For price context, ALKS is down 2.69% at $44.94. The most recent story, "Alkermes plc Enters Settlement Agreement With Teva Over LYBALVI Patent Litigation", was published by Nasdaq on Nov 12, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Alkermes headlines

Stocks mentioned alongside ALKS

Compare ALKS